Carlos A. Schuler
Fondateur chez InCarda Therapeutics, Inc.
Postes actifs de Carlos A. Schuler
Sociétés | Poste | Début | Fin |
---|---|---|---|
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Directeur Technique/Scientifique/R&D | 01/01/2009 | - |
Directeur des opérations | 01/01/2009 | - | |
Fondateur | 01/01/2009 | - | |
Directeur/Membre du Conseil | 01/01/2009 | - |
Historique de carrière de Carlos A. Schuler
Anciens postes connus de Carlos A. Schuler
Sociétés | Poste | Début | Fin |
---|---|---|---|
ForSight VISION5, Inc.
ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ. | Corporate Officer/Principal | 01/03/2013 | 01/08/2016 |
NEKTAR THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/01/2008 | 01/01/2008 |
Incline Therapeutics, Inc.
Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA. | Corporate Officer/Principal | - | - |
Aerometrics, Inc.
Aerometrics, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of TSI, Inc. (Minnesota), Aerometrics, Inc. develops and manufactures flow and particle measuring instruments. The company is based in Sunnyvale, CA. Aerometrics was acquired by TSI, Inc. (Minnesota) on October 10, 1995. | Directeur Technique/Scientifique/R&D | - | - |
Talima Therapeutics, Inc.
Talima Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talima Therapeutics, Inc. operated as a drug delivery company. It had developed a micro implant delivery technology for the localized application of small molecule drugs. The firm’s product was in phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the toenails. The company was founded in 2004 and was headquartered in San Carlos, CA. | Directeur des opérations | - | - |
S.E.A. Medical Systems, Inc.
S.E.A. Medical Systems, Inc. Medical SpecialtiesHealth Technology S.E.A. Medical Systems, Inc. develops medical devices that catch serious or life-threatening intravenous drug errors. It specializes in developing medical devices that catch serious or life-threatening intravenous drug errors before they harm patients. It has created a disruptive platform technology with life-saving product applications, allowing for the identification and characterization of medical solutions in real time. The firm offers IV Check that validates IV preparations and measures pharmacy returns to detect narcotic or scheduled drug diversion. The company was founded in October 2008 by James W. Bennett, Leo Matsiev and Michael J. Weickert and is headquartered in Emerald Hills, CA. | Corporate Officer/Principal | 01/05/2012 | - |
Anesiva, Inc.
Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 15/09/2009 | - |
Formation de Carlos A. Schuler
University of California, Berkeley | Doctorate Degree |
Universidad Simón Bolívar | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Vénézuela | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Chief Operating Officer | 2 |
Sectorielle
Health Technology | 7 |
Consumer Services | 3 |
Electronic Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
Entreprise privées | 7 |
---|---|
Anesiva, Inc.
Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Health Technology |
S.E.A. Medical Systems, Inc.
S.E.A. Medical Systems, Inc. Medical SpecialtiesHealth Technology S.E.A. Medical Systems, Inc. develops medical devices that catch serious or life-threatening intravenous drug errors. It specializes in developing medical devices that catch serious or life-threatening intravenous drug errors before they harm patients. It has created a disruptive platform technology with life-saving product applications, allowing for the identification and characterization of medical solutions in real time. The firm offers IV Check that validates IV preparations and measures pharmacy returns to detect narcotic or scheduled drug diversion. The company was founded in October 2008 by James W. Bennett, Leo Matsiev and Michael J. Weickert and is headquartered in Emerald Hills, CA. | Health Technology |
Talima Therapeutics, Inc.
Talima Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talima Therapeutics, Inc. operated as a drug delivery company. It had developed a micro implant delivery technology for the localized application of small molecule drugs. The firm’s product was in phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the toenails. The company was founded in 2004 and was headquartered in San Carlos, CA. | Health Technology |
Aerometrics, Inc.
Aerometrics, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of TSI, Inc. (Minnesota), Aerometrics, Inc. develops and manufactures flow and particle measuring instruments. The company is based in Sunnyvale, CA. Aerometrics was acquired by TSI, Inc. (Minnesota) on October 10, 1995. | Electronic Technology |
ForSight VISION5, Inc.
ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ. | Electronic Technology |
Incline Therapeutics, Inc.
Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA. | Health Technology |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Health Technology |
- Bourse
- Insiders
- Carlos A. Schuler
- Expérience